Status | Study |
COMPLETED |
Study Name: Bioequivalence Study of 2 Sizes of SHR4640 Tablets Orally in Healthy Subjects Condition: Hyperuricemia Date: 2023-12-05 Interventions: SHR4640, 2.5mg*4 - 10mg*1 |
Completed |
Study Name: Use of Febuxostat in Hyperuricemia Among Hemodialysis Patients Condition: Hyperuricemia Hemodialysis Complication Date: 2017-05-10 Interventions: Drug: Febuxostat 40 milligramsTablet Febuxostat 40 milligramsTablet every other day for 3 months |
Recruiting |
Study Name: Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout Condition: Hyperuricemia With or Without Gout Date: 2017-03-29 Interventions: Drug: FYU-981 Oral daily dosin |
Recruiting |
Study Name: Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types) Condition: Hyperuricemia Date: 2016-07-15 Interventions: Drug: FYU-981 Drug: Topiroxostat |
Recruiting |
Study Name: Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia Condition: Hyperuricemia Date: 2015-06-24 Interventions: Other: Uric acid level |
Withdrawn |
Study Name: Genetics of Hyperuricemia Therapy in Hmong Condition: Hyperuricemia, Gout Date: 2015-02-19 Interventions: Drug: Allopurinol |
Recruiting |
Study Name: Study of FYU-981 in Hyperuricemia With or Without Gout Condition: Hyperuricemia With or Without Gout Date: 2015-01-18 Interventions: Drug: FYU-981 |
Completed |
Study Name: A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia Patients Condition: Gout and Asymptomatic Hyperuricemia Date: 2014-12-09 Interventions: Drug: RDEA3170 Oral Treatment |
Completed |
Study Name: Effect of Chrysanthemum Flower Oil and Its Dose-dependency on Hyperuricemia Condition: Hyperuricemia Date: 2014-08-08 Interventions: Dietary Supplement: 200 mg of chrysanthemum flower oil |
Completed |
Study Name: Prednisone for Heart Failure Patients With Hyperuricemia Condition: Heart Failure Hyperuricemia Date: 2014-04-30 Interventions: Drug: prednisone 1 mg/kg/day w |